Dr. Christine Moore
Christine Moore is currently the Vice President of Toxicology Research and Development for Immunalysis Corporation, a company specializing in the development, manufacture and distribution of immunoassay systems for testing drugs of abuse in various biological matrices. She is the Director of the laboratory where the National Roadside Survey biological specimens were analyzed for the 2005 pilot study and for the 2007 expanded project.
Dr. Moore has a Bachelor of Science (Honors) degree in Applied Chemistry from the University of Salford, England (1985), a Master of Science degree in Forensic Science from the University of Strathclyde, Scotland (1986), and a Ph.D. in Forensic Toxicology from the University of Glasgow, Scotland (1989). She is Board Certified in Toxicological Chemistry by the American Board of Clinical Chemistry (DABCC), and is a Fellow of the Royal Society of Chemistry and the American Academy of Forensic Sciences.
Christine is currently the President of the Society of Forensic Toxicologists (SOFT) and Vice-President of the Society of Hair Testing. She is a member of the International Association of Toxicologists (TIAFT), the American Association of Clinical Chemistry (AACC), the Research Society on Alcoholism (RSA), the California Association of Toxicologists (CAT), and the International Council on Alcohol, Drugs and Traffic Safety (ICADTS), where she is Co-Chair of the Ethanol Biomarker Committee. Additionally, she is Past-President of the Mid-West Association for Toxicology and Therapeutic Drug Monitoring (MATT) and is past Chair of the Toxicology Section of the American Academy of Forensic Sciences. She serves on the Editorial Board of the Journal of Analytical Toxicology and is a reviewer for several other journals.
She currently has over 85 peer-reviewed publications regarding the analysis of drugs in biological matrices, including oral fluid, meconium and hair.
Adam Negrusz, Ph.D.
Veterinary Forensic Toxicology: The Detection of Illicit Substances and Performance Enhancing Drugs in Race Horses
Associate Professor, Assistant Director of Forensic Sciences, and the Director of Animal Forensic Toxicology Laboratory, Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago. His research interests focus on equine testing for illicit substances, drug-facilitated sexual assault, the development of the state-of-the-art chromatographic methods for the determination of drugs in biological specimens including hair, postmortem samples, forensic urine drug testing.
Dr. Negrusz received a Masters degree in Pharmacy from Nicholas Copernicus Medical University in Krakow, Poland (1981), and a Ph.D. in Pharmaceuti cal Sciences from the same University in Poland (1989). In 2001 he received a senior doctoral degree, Doctor Habilitatus, from Jagiellonian University, Krakow, Poland. Adam is a registered pharmacist (1981) and licensed toxicologist (1987) in Poland. After 8 years at the Department of Toxicology Medical University in Krakow, he joined the University of Illinois at Chicago in 1990 where he was conducting several studies including the analysis of meconium, amniotic fluid and umbilical cord for cocaine and its metabolites. After completion of his postdoctoral training he worked for one year as a toxicologist at the Cook County Office of the Medical Examiner.
In 1993 he re-joined University of Illinois and in 1995 became an Assistant Professor of Forensic Sciences. In 2002 he was promoted to the rank of Associate Professor with tenure. Currently Adam is involved as a coordinator and lecturer in courses required to obtain a Master of Sciences degree in Forensic Sciences. He also teaches professional PharmD students. Overall, he has 29 years of experience in academic forensic toxicology and drug analysis which has resulted in the publication of nearly 50 research articles, few book chapters, nearly 60 abstracts presented at scientific meetings, over 30 professional analytical chemistry reports for sponsors and many standard operating procedures (SOP). He is a Fellow (Toxicology Section) of the American Academy of Forensic Sciences where he served for one year as a Section Chair, a member of the Society of Forensic Toxicologists (SOFT), The International Association of Forensic Toxicologists (TIAFT), an affiliate member of the Association of Official Racing Chemists, the Society of Hair Testing, and Polish Society of Toxicology.
“Pain Management and the Clinical Toxicology Lab”
In a country where the number of narcotics deaths involving prescription opioid analgesics increased 160% from 1999 to 2004, and 55% of all drug misuse/abuse ER visits in 2006 involved illicit drugs, physicians who treat chronic pain are more aware than ever of their responsibility to curb abuse and reduce harm, while at the same time provide effective care for their patients. Assessment of pain severity is often a subjective exercise for the physician, and when a practitioner makes a decision to treat the pain pharmacologically, objective evidence of compliance with the prescription regimen is crucial. The laboratory’s role is to provide that objective evidence, through measurement of drug and metabolite in a patient’s biological specimens.